Journal: Pharmaceutics

Article Title: Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs

doi: 10.3390/pharmaceutics13020290

Figure Lengend Snippet: Summary of celecoxib (CLX), tenoxicam (TNX) and dexamethasone (DEX) properties related to the treatment of osteoarthritis (OA).

Article Snippet: Celecoxib (CLX, Sigma-Aldrich), dexamethasone (DEX, Sigma-Aldrich), tenoxicam (TNX, Alfa Aesar, Kandel, Germany) and ethanol (VWR, Matsonford Road, Radnor, PA, USA) were used as received for the synthesis of the NPs.

Techniques: Inhibition, Binding Assay, Solubility, Injection

Journal: RSC Advances

Article Title: Thiosemicarbazide functionalized carbon quantum dots as a fluorescent probe for the determination of some oxicams: application to dosage forms and biological fluids †

doi: 10.1039/d2ra01040b

Figure Lengend Snippet: Application of the proposed method for the determination of PRX, TNX and LRX in their pharmaceutical preparations

Article Snippet: - Tenoxicam pure sample (TNX) was supplied by the Egyptian International Pharmaceutical Industries Co. EIPICO, 10 th of Ramadan City, Industrial Zone B1, Egypt.

Techniques: Comparison

Journal: Indian Journal of Pharmaceutical Sciences

Article Title: Development and Validation of HPTLC Method for Estimation of Tenoxicam and its Formulations

doi: 10.4103/0250-474X.102541

Figure Lengend Snippet: Three dimentional overlay of HPTLC densitograms of standard plot of tenoxicam. Analysis was done using 60F-254 TLC plates as stationery phase and toluene-ethyl acetate-formic acid (6:4:0.3, v/v/v) as mobile phase.

Article Snippet: Tenoxicam was procured as a gift sample from Ranbaxy Pharmaceuticals Ltd., Devas (M.P.), India.

Techniques: High Performance Thin Layer Chromatography

Journal: Indian Journal of Pharmaceutical Sciences

Article Title: Development and Validation of HPTLC Method for Estimation of Tenoxicam and its Formulations

doi: 10.4103/0250-474X.102541

Figure Lengend Snippet: Linear regression curve of the tenoxicam standard plot The regression coefficient was found to be r2= 0.9978 for the equation y=18.481x-14.712

Article Snippet: Tenoxicam was procured as a gift sample from Ranbaxy Pharmaceuticals Ltd., Devas (M.P.), India.

Techniques:

Journal: Indian Journal of Pharmaceutical Sciences

Article Title: Development and Validation of HPTLC Method for Estimation of Tenoxicam and its Formulations

doi: 10.4103/0250-474X.102541

Figure Lengend Snippet: Overlay of HPTLC densitograms of (a) Tenoxicam standard, (b) Formulation I, (c) Formulation II, (d) Formulation III. Analysis was done using 60F-254 TLC plates as stationery phase and toluene-ethyl acetate-formic acid (6:4:0.3, v/v/v) as mobile phase

Article Snippet: Tenoxicam was procured as a gift sample from Ranbaxy Pharmaceuticals Ltd., Devas (M.P.), India.

Techniques: High Performance Thin Layer Chromatography, Formulation

Journal: International Journal of Clinical and Experimental Medicine

Article Title: Intra-articular hyaluronate, tenoxicam and vitamin E in a rat model of osteoarthritis: evaluation and comparison of chondroprotective efficacy

doi:

Figure Lengend Snippet: Total Mankin Scores of treatment and control groups and comparison of groups in terms of total Mankin scores

Article Snippet: Third group received 0.2 ml intra-articular injections of tenoxicam (20 mg/2 ml, Oksamen, Mustafa Nevzat, Turkey) and fourth group received 0.2 ml intra-articular injections of Vit E (300 mg/2 ml alpha tocoferol asetat, Evigen, Mefar, Turkey).

Techniques: Control, Comparison

Journal: International Journal of Clinical and Experimental Medicine

Article Title: Intra-articular hyaluronate, tenoxicam and vitamin E in a rat model of osteoarthritis: evaluation and comparison of chondroprotective efficacy

doi:

Figure Lengend Snippet: Structure scores of treatment and control groups and comparison of groups in terms of structure scores

Article Snippet: Third group received 0.2 ml intra-articular injections of tenoxicam (20 mg/2 ml, Oksamen, Mustafa Nevzat, Turkey) and fourth group received 0.2 ml intra-articular injections of Vit E (300 mg/2 ml alpha tocoferol asetat, Evigen, Mefar, Turkey).

Techniques: Control, Comparison

Journal: International Journal of Clinical and Experimental Medicine

Article Title: Intra-articular hyaluronate, tenoxicam and vitamin E in a rat model of osteoarthritis: evaluation and comparison of chondroprotective efficacy

doi:

Figure Lengend Snippet: Cells scores of treatment and control groups and comparison of groups in terms of cells scores

Article Snippet: Third group received 0.2 ml intra-articular injections of tenoxicam (20 mg/2 ml, Oksamen, Mustafa Nevzat, Turkey) and fourth group received 0.2 ml intra-articular injections of Vit E (300 mg/2 ml alpha tocoferol asetat, Evigen, Mefar, Turkey).

Techniques: Control, Comparison

Journal: International Journal of Clinical and Experimental Medicine

Article Title: Intra-articular hyaluronate, tenoxicam and vitamin E in a rat model of osteoarthritis: evaluation and comparison of chondroprotective efficacy

doi:

Figure Lengend Snippet: Safranin-O staining scores of experimental and control groups and comparison of groups in terms of Safranin-O staining scores

Article Snippet: Third group received 0.2 ml intra-articular injections of tenoxicam (20 mg/2 ml, Oksamen, Mustafa Nevzat, Turkey) and fourth group received 0.2 ml intra-articular injections of Vit E (300 mg/2 ml alpha tocoferol asetat, Evigen, Mefar, Turkey).

Techniques: Staining, Control, Comparison

Journal: International Journal of Clinical and Experimental Medicine

Article Title: Intra-articular hyaluronate, tenoxicam and vitamin E in a rat model of osteoarthritis: evaluation and comparison of chondroprotective efficacy

doi:

Figure Lengend Snippet: Microscopic evaluation of Safranin-O Staining subcategory of Mankin Grading System: Intensity of Safranin-O staining is directly proportional to the proteoglycan content of the cartilage. A: Normal staining (Hematoxylin and Eosin×200) (HA group). B: Slight reduction in Safranin-O staining (Hematoxylin and Eosin×400) (tenoxicam group). C: Severe reduction in Safranin-O staining (Hematoxylin and eosin×400) (control group).

Article Snippet: Third group received 0.2 ml intra-articular injections of tenoxicam (20 mg/2 ml, Oksamen, Mustafa Nevzat, Turkey) and fourth group received 0.2 ml intra-articular injections of Vit E (300 mg/2 ml alpha tocoferol asetat, Evigen, Mefar, Turkey).

Techniques: Staining, Control